Rejuve Meds review
Graded on whether a price is published, checkable, and still true at month two — how we grade · how we verify prices
Rejuve Meds prints two prices and no plan ladder: semaglutide injections at $165 per month, tirzepatide at $265 per month, with nothing else attached.
- Month-to-month price published
- States not published
- FDA warning letters: 0 of 0 matched
- Prices read September 2026
Read first-hand, not from a feed.
Distinct plans priced.
This link pays us nothing. It's here because the price is checkable.
The verdict
Refreshingly plain on price and unusually thin on everything else. Two figures written as “per month”, no first-month trick and no commitment tiers — and also no product pages, no address and no word about which states it can serve.
This link pays us nothing. It's here because the price is checkable.
Quick facts
Key facts
- Semaglutide injections
- $165 per month
- Tirzepatide injections
- $265 per month
- Plan tiers
- None published — one price per product
- First-month rate
- None published
- Product pages
- None — the price strip is the whole catalog
- Legal entity
- Rejuve, Inc.
- Address, pharmacy, states
- None of the three is published
Pros and cons
What we like
- Writes both prices as “per month” with no term or commitment attached.
- Publishes no introductory rate, so there is no month-two surprise to find.
- Names the owning company in its terms of use.
- Keeps the offer to two products, priced identically wherever they appear.
What could be better
- No product page for either drug, so “per month” is the entire specification.
- No dose range, supply quantity or flat-dose promise anywhere.
- A first-order discount banner runs above the prices with no stated relationship to them.
- No postal address, no named pharmacy and no state disclosure of any kind.
- The legal pages carry a stale copyright year.
What it is
Rejuve Meds is a small telehealth storefront selling two compounded GLP-1 injections. The terms of use name Rejuve, Inc. as the owner and operator of the site. There is no catalog beyond the two products, and no product page for either: the whole offer is a two-card strip that renders at the top of every page, and the intake sits on a separate subdomain.
That thinness cuts both ways. There is very little here to mislead anyone — but there is also very little to check.
Every price we found
| Plan | Advertised | What you actually pay | The gap | Read on |
|---|---|---|---|---|
| Semaglutide injectionsWritten as “per month”. No plan length, dose range or supply quantity is stated. | not published | $165 | not comparable | September 2026 |
| Tirzepatide injectionsAlso written as “per month”, described as a dual-action compounded formulation. | not published | $265 | not comparable | September 2026 |
This link pays us nothing. It's here because the price is checkable.
What it actually costs
“Semaglutide Injections per month $165” and “Tirzepatide Injections per month $265” — written as monthly prices, with no plan tiers and no first-month rate anywhere.
There is no ladder to decode and no introductory figure that becomes something else in month two, which is the single most common pattern on this roster and the one this site grades hardest. What a reader cannot learn is what the money buys beyond the words “per month”: no dose range is stated, no supply quantity, and nothing about whether the figure holds as a clinician titrates the dose up. That last point is the question a flat monthly figure usually hides.
A promotional banner offers $120 off a first order, and nothing on the page says how that interacts with the $165.
Who it's wrong for
- Anyone who wants to know what the price covers. There is no product page for either drug.
- Anyone expecting the price to hold as the dose rises. The site makes no flat-dose promise either way.
- Anyone who needs an address, a named pharmacy or a state list. None is published.
- Anyone checking how current the site is. Its own terms page still carries a 2025 copyright line.
Medications available
- Semaglutide injectionsCompounded$165 per month
One weekly injection, per the card. No dose range is published.
- Tirzepatide injectionsCompounded$265 per month
Described as a dual-action GLP-1/GIP compounded formulation.
Is Rejuve Meds legit?
Rejuve Meds is operated by Rejuve, Inc.. We read that off the company’s own terms of use on September 2026.
What that means
A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.Pharmacy, prescribers and safety checks
- Legal entityRejuve, Inc.
- Postal addressNot disclosed
- Pharmacy namedNot disclosed
- Drug formCompounded
- States servedNot disclosed
Common questions
How much does Rejuve Meds cost per month?
Semaglutide injections are listed at $165 per month and tirzepatide injections at $265 per month. Those are the only two figures the site publishes.
Does Rejuve Meds have a cheaper first month?
It publishes no introductory rate. A banner advertises a flat discount on a first order, but the site never explains how that interacts with either monthly figure, or whether it applies to both drugs.
Does the Rejuve Meds price change with the dose?
The site does not say. There is no product page for either drug and no dose range is published anywhere, so nothing states whether the figure holds as a clinician titrates upward.
Who operates Rejuve Meds?
Its terms of use name Rejuve, Inc. as the owner and operator of the website. No postal address appears on any page we read.
Why we gave Rejuve Meds a B
Read the full grading rationale
Rejuve Meds does the simple thing: two products, two prices, both written as "per month" with nothing qualifying them — $165 for semaglutide injections and $265 for tirzepatide. There is no plan ladder to decode, no first-month rate that turns into something else in month two, and no membership fee hiding underneath. The terms of use name Rejuve, Inc. as the owner and operator of the site. Three things hold it at B rather than higher. The prices live in a product strip and nowhere else: the company publishes no product page for either drug, so "per month" is the entire specification of what the money buys — no dose range, no supply length, nothing about what happens when a clinician titrates the dose up. A promotional banner runs above it offering "$120 off" a first order, and the relationship between that discount and the $165 is never stated. And the company publishes no postal address, names no compounding pharmacy, and makes no statement at all about which states it can serve. Its own terms page still carries a 2025 copyright line, which is a small sign of how closely the legal pages are maintained.
What that means
Screening is by entity — the company’s own domain plus the address it publishes — never by brand name, because a brand name matches every namesake. Where a company publishes no address, the address half of that match is never exercised, and the result is recorded as the weaker kind of absence rather than a clean record. A known-positive control passed in the same run, so a real match would have surfaced. A letter would be worth knowing about; it would not by itself disqualify a seller.How we reviewed Rejuve Meds
- We read the homepage, the contact page and the terms of use in full on 2026-09-12. The two prices render in a product strip at the top of every page, including the terms page this review cites.
- The terms page is cited rather than the homepage on purpose: a price read from a bare domain root is not a citable source under this site's own rule, and this company publishes no product page for either drug.
- Before reading anything we ran a nonsense path on the same host in the same session. It returned HTTP 404 with a 33-character body, distinct from every real page.
- The FDA warning-letter screen ran on the company's own domain with a known-positive and a known-negative control passing in the same run. No address is published, so the address half of the match could never have run.
The page we read — all on
- Terms page
My Account Contact Most Popular Semaglutide Injections per month $165 GLP-1 weight loss support One simple injection per week Get started Dual Action Tirzepatide Injections per month $265 Dual-action GLP-1/GIP compounded formulation One simple injection per week Get started
This link pays us nothing. It's here because the price is checkable.
Alternatives to Rejuve Meds
| Provider | Grade | Cheapest price |
|---|---|---|
| Lyfe RX | CCaveat | $166.5/mo |
| WeightlessRx | CCaveat | $167/mo |
| HumeCare+ | FFail | $169/mo |
| Effecty | BMinor gap | $170/mo |
| LifespanningRx | AVerified | $170/mo |